Andrew Bismark

Title(s)Associate Clinical Professor, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pupillary responses as a biomarker of cognitive effort and the impact of task difficulty on reward processing in schizophrenia. Schizophr Res. 2024 May; 267:216-222. Bismark AW, Mikhael T, Mitchell K, Holden J, Granholm E. PMID: 38569395.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: a retrospective clinical study. J Clin Sleep Med. 2023 12 01; 19(12):2043-2051. Titone MK, Hunt C, Bismark A, Nokes B, Lee E, Ramanathan D, Park J, Colvonen P. PMID: 37539643; PMCID: PMC10692930.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Correction to: Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. Transl Psychiatry. 2022 Jul 21; 12(1):290. Cavanagh JF, Gregg D, Light GA, Olguin SL, Sharp RF, Bismark AW, Bhakta SG, Swerdlow NR, Brigman JL, Young JW. PMID: 35864090; PMCID: PMC9304120.
      View in: PubMed   Mentions:    Fields:    
    4. Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series. EClinicalMedicine. 2022 Jun; 48:101439. Artin H, Bentley S, Mehaffey E, Liu FX, Sojourner K, Bismark AW, Printz D, Lee EE, Martis B, De Peralta S, Baker DG, Mishra J, Ramanathan D. PMID: 35706484; PMCID: PMC9092498.
      View in: PubMed   Mentions: 7  
    5. Response to intravenous racemic ketamine after switch from intranasal (S)-ketamine on symptoms of treatment-resistant depression and post-traumatic stress disorder in Veterans: A retrospective case series. Pharmacotherapy. 2022 03; 42(3):272-279. Bentley S, Artin H, Mehaffey E, Liu F, Sojourner K, Bismark A, Printz D, Lee EE, Martis B, De Peralta S, Baker DG, Mishra J, Ramanathan D. PMID: 35122282; PMCID: PMC8934379.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    6. Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. Transl Psychiatry. 2021 09 17; 11(1):482. Cavanagh JF, Gregg D, Light GA, Olguin SL, Sharp RF, Bismark AW, Bhakta SG, Swerdlow NR, Brigman JL, Young JW. PMID: 34535625; PMCID: PMC8448772.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    7. The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia. Schizophr Res. 2022 05; 243:372-382. Clayson PE, Joshi YB, Thomas ML, Tarasenko M, Bismark A, Sprock J, Nungaray J, Cardoso L, Wynn JK, Swerdlow NR, Light GA. PMID: 34187732.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Associations between veteran encounters with suicide prevention team and suicide-related outcomes. Suicide Life Threat Behav. 2021 08; 51(4):729-735. Doran N, Bismark A, Khalifian C, Mishra J, De Peralta S, Martis B. PMID: 33904613.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophr Res. 2019 06; 208:384-389. Joshi YB, Thomas ML, Hochberger WC, Bismark AW, Treichler EBH, Molina J, Nungaray J, Cardoso L, Sprock J, Swerdlow NR, Light GA. PMID: 30738698; PMCID: PMC8215853.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    10. Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia. Schizophr Res. 2019 08; 210:215-220. Treichler EBH, Thomas ML, Bismark AW, Hochberger WC, Tarasenko M, Nungaray J, Cardoso L, Joshi YB, Zhang W, Sprock J, Swerdlow N, Cohen AN, Light GA. PMID: 30660574; PMCID: PMC7032664.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Multiple Dissociations Between Comorbid Depression and Anxiety on Reward and Punishment Processing: Evidence From Computationally Informed EEG. Comput Psychiatr. 2019 Jan; 3:1-17. Cavanagh JF, Bismark AW, Frank MJ, Allen JJB. PMID: 31149639; PMCID: PMC6515849.
      View in: PubMed   Mentions: 18  
    12. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia. Neuropsychopharmacology. 2019 02; 44(3):606-612. Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. PMID: 30377381; PMCID: PMC6333927.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    13. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophr Res. 2018 12; 202:378-384. Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, Light GA. PMID: 30055883; PMCID: PMC7409526.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    14. Computerized cognitive training is associated with improved psychosocial treatment engagement in schizophrenia. Schizophr Res. 2018 12; 202:341-346. Thomas ML, Treichler EBH, Bismark A, Shiluk AL, Tarasenko M, Zhang W, Joshi YB, Sprock J, Cardoso L, Tiernan K, Light GA. PMID: 29929773; PMCID: PMC7409521.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    15. Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia. Transl Psychiatry. 2018 04 12; 8(1):80. Bismark AW, Thomas ML, Tarasenko M, Shiluk AL, Rackelmann SY, Young JW, Light GA. PMID: 29643355; PMCID: PMC5895589.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Relationship between effortful motivation and neurocognition in schizophrenia. Schizophr Res. 2018 03; 193:69-76. Bismark AW, Thomas ML, Tarasenko M, Shiluk AL, Rackelmann SY, Young JW, Light GA. PMID: 28673753; PMCID: PMC5754266.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    17. Evidence of systematic attenuation in the measurement of cognitive deficits in schizophrenia. J Abnorm Psychol. 2017 Apr; 126(3):312-324. Thomas ML, Patt VM, Bismark A, Sprock J, Tarasenko M, Light GA, Brown GG. PMID: 28277736; PMCID: PMC5378601.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task. Neuropsychopharmacology. 2017 May; 42(6):1338-1348. Young JW, Bismark AW, Sun Y, Zhang W, McIlwain M, Grootendorst I, Light GA. PMID: 27917869; PMCID: PMC5437886.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    19. The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service. BMC Psychiatry. 2015 Oct 28; 15:266. Breitborde NJ, Bell EK, Dawley D, Woolverton C, Ceaser A, Waters AC, Dawson SC, Bismark AW, Polsinelli AJ, Bartolomeo L, Simmons J, Bernstein B, Harrison-Monroe P. PMID: 26511605; PMCID: PMC4625429.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    20. Meta-cognitive skills training enhances computerized cognitive remediation outcomes among individuals with first-episode psychosis. Early Interv Psychiatry. 2017 06; 11(3):244-249. Breitborde NJK, Woolverton C, Dawson SC, Bismark A, Bell EK, Bathgate CJ, Norman K. PMID: 26472632.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    21. The role of outcome expectations in the generation of the feedback-related negativity. Psychophysiology. 2013 Feb; 50(2):125-33. Bismark AW, Hajcak G, Whitworth NM, Allen JJ. PMID: 23153354; PMCID: PMC3540152.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    22. Larger Error Signals in Major Depression are Associated with Better Avoidance Learning. Front Psychol. 2011; 2:331. Cavanagh JF, Bismark AJ, Frank MJ, Allen JJ. PMID: 22084638; PMCID: PMC3210982.
      View in: PubMed   Mentions: 30  
    23. Diagnosing premenstrual dysphoric disorder: the reliability of a structured clinical interview. Arch Womens Ment Health. 2011 Jun; 14(3):265-7. Accortt EE, Bismark A, Schneider TR, Allen JJ. PMID: 21336934.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Resting frontal EEG asymmetry as an endophenotype for depression risk: sex-specific patterns of frontal brain asymmetry. J Abnorm Psychol. 2010 Aug; 119(3):502-12. Stewart JL, Bismark AW, Towers DN, Coan JA, Allen JJ. PMID: 20677839; PMCID: PMC2916182.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    25. Polymorphisms of the HTR1a allele are linked to frontal brain electrical asymmetry. Biol Psychol. 2010 Feb; 83(2):153-8. Bismark AW, Moreno FA, Stewart JL, Towers DN, Coan JA, Oas J, Erickson RP, Allen JJ. PMID: 20025927; PMCID: PMC2845287.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    26. Visual event-related potentials in schizotypal personality disorder and schizophrenia. J Abnorm Psychol. 2008 Feb; 117(1):119-31. Vohs JL, Hetrick WP, Kieffaber PD, Bodkins M, Bismark A, Shekhar A, O'Donnell BF. PMID: 18266490.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. Cerebellum volume and eyeblink conditioning in schizophrenia. Psychiatry Res. 2008 Apr 15; 162(3):185-94. Edwards CR, Newman S, Bismark A, Skosnik PD, O'Donnell BF, Shekhar A, Steinmetz JE, Hetrick WP. PMID: 18222655; PMCID: PMC2366060.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    28. Early stage vision in schizophrenia and schizotypal personality disorder. Schizophr Res. 2006 Sep; 86(1-3):89-98. O'Donnell BF, Bismark A, Hetrick WP, Bodkins M, Vohs JL, Shekhar A. PMID: 16829048.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    Andrew's Networks
    Concepts (112)
    Derived automatically from this person's publications.
    Co-Authors (20)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department